C20H25N5
Neat
335.46
-20°C
Room Temperature
1252883-90-1; N-((3S, 4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-amine; N-[(3S, 4S)-1-Benzyl-4-methylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-amine; 7H-Pyrrolo[2, 3-d]pyrimidin-4-amine, N-methyl-N-[(3S, 4S)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-; N-Methyl-N-[(3S, 4S)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7H-pyrrolo[2, 3-d]pyrimidin-4-amine; N-((3S, 4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-amine; Tofacitinib Impurity X; SCHEMBL28403926; MFCD30063201; DB-255346; CS-0166069; F90367; N-[(3S, 4S)-1-benzyl-4-methyl-3-piperidyl]-N-methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-amine; N-((3S, 4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2 and 3-d]pyrimidin-4-amine (Tofacitinib Impurity
N-[(3S, 4S)-1-benzyl-4-methylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2 and 3-d]pyrimidin-4-amine
InChI=1S/C20H25N5/c1-15-9-11-25(12-16-6-4-3-5-7-16)13-18(15)24(2)20-17-8-10-21-19(17)22-14-23-20/h3-8,10,14-15,18H,9,11-13H2,1-2H3,(H,21,22,23)/t15-,18+/m0/s1